
Breelyn Wilky, MD π
@breelynwilkymd
Director, Sarcoma Oncology, @CUCancerCenter. Immunotherapy translational researcher. Tweets reflect my own opinions.
ID: 2576618712
http://breelynwilkymd.com 19-06-2014 10:28:35
1,1K Tweet
2,2K Followers
557 Following


CU Cancer Center members Breelyn Wilky, MD π, and Steven Thorpe, MD, FACS, discuss what is sarcoma for #SarcomaAwarenessMonth. Stay tuned for more questions and answers about sarcoma! You also can find information about sarcoma on our webpage here: bit.ly/3RLxO4J

Thrilled to be partnering with Dr Steven Thorpe, our new Chief of Musculoskeletal Oncology in Orthopedics at CU Cancer Center - our #sarcoma patients will benefit so much from his experience and perspectives! #sarcomaawareness

Thrilled to host TGCT Support in Colorado for Day of Learning! Amazing turnout! Thanks to Sydney Stern, PhD, MS The Life Raft Group , our faculty speakers and our sponsors!



New podcast from my colleague Dr Eduardo Davila β¦Dr.Davilaβs Immunology Labβ© which is a great laymanβs summary of #TIL therapy! Very excited to be a part of this initiative and canβt wait to see it in patients! β¦CU Cancer Centerβ© news.cuanschutz.edu/news-stories/bβ¦

This is AMAZING!!!! So grateful from #teamsarcoma CU Cancer Center to support critical research for patients! Thank you John Franklin-Myers Denver Broncos !!! Hope to see you at #racetocuresarcoma denver Sarcoma Foundation of America!!!


Don't forget to mark your calendar and claim your spot in this insightful webinar reviewing important new data and discussing updates on the treatment of gastrointestinal stromal tumors (GIST). Jason Sicklick Neeta Somaiah, MD Breelyn Wilky, MD π Register Now: ow.ly/lZWb50U86f3



Join us in Boulder, CO April 3, 2025 for inaugural Rocky Mountain #Sarcoma Symposium! incredible speakers Sandra P D'Angelo, MD Jason Sicklick Richard Gorlick R. Lor Randall and Kaled Alektiar - register here: bit.ly/49v1gU5 time for β·οΈ afterwards! CU Cancer Center



Love OncLive.com Breelyn Wilky, MD π #GIST : onclive.com/insights/my-trβ¦


Thank you to Clinical Cancer Research Agenus Cancer League Colo CU Cancer Center for support in this investigator initiated study, doxorubicin plus dual checkpoint inhibitors for advanced sarcomas!